gvtcx

Breast Cancer Oncotype Testing

Lincolnshire Partnership NHS Foundation Trust Published 26 Apr 2024 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£490,050
Statuscomplete
Category (CPV) 85111800
Deadline11 Mar 2024
Contract start12 Mar 2024
Contract end11 Mar 2027
Procedureselective
SME suitableNo
OCIDocds-b5fd17-f55da915-d7ac-4905-81e4-f1b6cf18c999

Award

SupplierValueDateStatus
Exact Sciences UK, Ltd. £490,050 14 Apr 2024 active

description

Provision of Prognostic Genetic Testing for Breast Cancer Patients - to Improve availability of Oncotype DX to Breast cancer patients, reducing the need for post-operative chemotherapy.

Additional information:

Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service 2023/S 000-028831,

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
26 Apr 2024 Award (award) · 0db1b1d6-da40-4244-9eb1-58948b0ce6ec-744894

more from Lincolnshire Partnership NHS Foundation Trust

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.